Kay-Cee-L (Potassium Chloride)

After oral ingestion, potassium chloride dissociates, releasing potassium ions that are absorbed into the bloodstream. The added potassium raises serum potassium concentrations, correcting deficits and supporting the Na⁺/K⁺‑ATPase pump, which maintains cellular electrical stability and muscle contractility.

The dose of Kay-Cee-L is individualized by the prescribing clinician based on the patient’s serum potassium level, renal function, and overall clinical condition. Only a qualified health professional should determine the appropriate amount and dosing schedule.

Safety data for potassium chloride in pregnancy and lactation are limited. Use is only recommended if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by the treating physician.

To request Kay-Cee-L, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kay-Cee-L contains potassium chloride, the most common and bioavailable form of oral potassium. Compared with potassium citrate or gluconate, chloride provides a higher elemental potassium per dose and is widely used for rapid correction of hypokalemia. Brand‑specific differences are mainly related to manufacturing quality and regulatory compliance.

Store Kay-Cee-L at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposure to extreme heat or humidity to maintain potency.

Kay-Cee-L is taken orally, usually with a full glass of water. It should be swallowed whole unless the prescriber advises otherwise. The tablet can be taken with or without food, but consistent administration with respect to meals helps maintain stable absorption.

The most serious risks include hyperkalemia, which can cause cardiac arrhythmias, muscle weakness, and in severe cases, cardiac arrest. Patients should be monitored for signs of elevated potassium, especially if they have renal impairment or are using other potassium‑raising medications.

Kay-Cee-L should be avoided in individuals with known hyperkalemia, severe renal failure, or conditions that predispose to high potassium levels such as adrenal insufficiency. It is also contraindicated in patients taking certain potassium‑sparing drugs without close medical supervision.